Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Richard A. Wells
Management of Cytopenias During Treatment With Lenalidomide in Patients With Myelodysplastic Syndromes
The Open Leukemia Journal
Targeted Deletion of a High-Affinity GATA-binding Site in the GATA-1 Promoter Leads to Selective Loss of the Eosinophil Lineage in Vivo
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Related publications
Relationship of Treatment-Related Cytopenias and Response to Lenalidomide in Patients With Lower-Risk Myelodysplastic Syndromes
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Impact of Lenalidomide Use Among Non-Transfusion Dependent Patients With Myelodysplastic Syndromes
American Journal of Hematology
Hematology
Lenalidomide: Targeted Anemia Therapy for Myelodysplastic Syndromes
Cancer Control
Medicine
Oncology
Hematology
Phase I Dose Escalation Study of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
Leukemia Research
Cancer Research
Oncology
Hematology
Improving Prognostic Tools for Patients With Myelodysplastic Syndromes
Mayo Clinic Proceedings
Medicine
Cost Effectiveness of Lenalidomide in the Treatment of Transfusion-Dependent Myelodysplastic Syndromes in the United States
Cancer Control
Medicine
Oncology
Hematology
Landscape of Genetic Lesions in 944 Patients With Myelodysplastic Syndromes
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Practical Considerations in the Use of Lenalidomide Therapy for Myelodysplastic Syndromes
Cancer Control
Medicine
Oncology
Hematology
Assessment of ATRX Expression in Patients With Myelodysplastic Syndromes Treated With Decitabine
Leukemia Research
Cancer Research
Oncology
Hematology
